The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

HIK HIKMA PHARMACEUTICALS PLC ORD SHS 10P



Income Statement  (£ m) 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Continuing Operations
Revenue  590.71 682.25 827.77 956.66 971.99
Operating Profit/(Loss)  76.37 102.74 213.46 258.28 257.17
Net Interest  8.85 13.53 13.34 12.85 27.00
Profit Before Tax  60.42 81.21 180.72 232.58 214.65
Profit After Tax  53.71 65.83 130.99 181.18 171.45
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  53.71 65.83 130.99 181.18 171.45
Attributable to:
Minority Interests  -2.16 -4.31 -2.43 -2.57 -1.35
Equity Holders of Parent Company  51.55 61.52 128.56 178.61 170.10
 
Continuing EPS
Earnings per Share - Basic  26.58p 31.44p 65.25p 90.21p 85.45p
Earnings per Share - Diluted  26.06p 31.13p 64.95p 89.31p 84.64p
Earnings per Share - Adjusted  33.46p 37.77p 84.35p 97.02p 97.00p
Continuing and Discontinued EPS
Earnings per Share - Basic  26.58p 31.44p 65.25p 90.21p 85.45p
Earnings per Share - Diluted  26.06p 31.13p 64.95p 89.31p 84.64p
Earnings per Share - Adjusted  33.46p 37.77p 84.35p 97.02p 97.00p
 
Dividend per Share  8.16p 8.29p 11.08p 12.00p 16.77p

Balance Sheet  (£ m) 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Assets
Non-Current Assets
Property, Plant & Equipment  228.20 220.86 234.69 286.55 284.17
Intangible Assets  263.05 266.38 271.07 386.78 409.72
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  24.09 23.99 33.96 10.28 4.73
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  73.91 71.98 86.11 111.79 136.35
  589.25 583.21 625.83 795.39 834.97
Current Assets
Inventories  153.95 167.33 167.38 175.40 169.42
Trade & Other Receivables  208.04 203.63 270.47 290.40 348.30
Cash at Bank & in Hand  62.62 108.89 101.88 179.90 373.27
Current Asset Investments  0.00 1.23 4.25 5.14 27.00
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  424.61 481.08 543.97 650.84 917.99
 
Total Assets  1013.86 1064.29 1169.80 1446.23 1752.95
 
Liabilities
Current Liabilities
Borrowings  -92.90 -120.58 -97.03 -253.14 -78.30
Other Current Liabilities  -157.38 -166.72 -258.34 -287.19 -321.30
  -250.27 -287.30 -355.37 -540.33 -399.60
 
Net Current Assets  174.34 193.79 188.60 110.51 518.39
 
Non-Current Liabilities
Borrowings  -233.59 -238.70 -171.01 -107.94 -413.10
Provisions  -14.89 -14.15 -15.77 -16.06 -14.18
Other Non-Current Liabilities  -1.21 -2.46 -0.61 -0.64 -13.50
  -249.70 -255.31 -187.39 -124.64 -440.77
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -499.97 -542.60 -542.76 -664.97 -840.37
 
Net Assets  513.89 521.69 627.05 781.26 912.59
 
Capital & Reserves
Share Capital  22.46 21.53 21.23 22.49 23.63
Share Premium Account  178.94 171.64 170.41 180.54 190.35
Other Reserves  5.17 -6.15 -6.67 566.03 688.49
Retained Earnings  293.12 325.44 431.78 0.00 0.00
Shareholders Funds  499.69 512.46 616.74 769.05 902.46
 
Minority Interests/Other Equity  14.19 9.23 10.31 12.21 10.13
Total Equity  513.89 521.69 627.05 781.26 912.59

Ratios - based on IFRS 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Continuing Operations
PE Ratio - Adjusted  18.53 20.15 14.24 20.40 23.72
PEG - Adjusted  -8.20 1.56 0.12 1.36 -1186.00
Earnings per Share Growth - Adjusted  -2.26% 12.89% 123.32% 15.01% -0.02%
Dividend Cover  4.10 4.55 7.61 8.08 5.78
Revenue Per Share  304.28p 348.09p 420.19p 483.16p 488.44p
Pre-Tax Profit per Share  31.12p 41.43p 91.73p 117.46p 107.86p
Operating Margin  11.80% 13.71% 23.59% 25.39% 24.72%
Return on Capital Employed  11.70% 15.07% 30.33% 31.81% 23.96%
 
Continuing & Discontinued Operations
Dividend Yield  1.32% 1.09% 0.92% 0.61% 0.73%
Dividend per Share Growth  1.94% 1.70% 33.59% 8.30% 39.78%
Net Asset Value per Share (exc. Intangibles)  120.84p 124.89p 174.80p 192.46p 246.37p
Net Gearing  52.81% 48.86% 26.94% 23.56% 13.09%

Data is provided by Morningstar


Market

Company Information
Updated Monthly
Company address 13 Hanover Square, London, W1S 1HW, United Kingdom
Company website http://www.hikma.com
Market cap(in millions)* £ 5,457.99
Listing/Admission to trading 04 Nov 2005
Trading service SETS
Market MAINMARKET
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
26-May-16
FTSE index FTSE All-Share,FTSE 350 Low Yield,FTSE 250,FTSE All-Share (ex IT),FTSE 350 (ex IT),FTSE MID 250 (ex IT),FTSE 350
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment STMM
MiFID Status Regulated Market
Exchange market size 1,000
SEDOL B0LCW08
ISIN number GB00B0LCW083



HIKMA share fundamentals (HIK)